Marshall Wace’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-674,698	Closed	-$78.1M	–	2975
2023 Q3	$78.1M	Buy	674,698 +52,484	+8%	+$5.64M	0.17%	124
2023 Q2	$64M	Buy	622,214 +221,893	+55%	+$23.4M	0.14%	172
2023 Q1	$43.7M	Sell	400,321 -66,970	-14%	-$7.4M	0.11%	246
2022 Q4	$53.2M	Sell	467,291 -2,039,038	-81%	-$169M	0.14%	187
2022 Q3	$155M	Buy	2,506,329 +2,347,834	+1,481%	+$164M	0.39%	46
2022 Q2	$12.6M	Sell	158,495 -499,611	-76%	-$47.3M	0.03%	708
2022 Q1	$69.2M	Sell	658,106 -998,573	-60%	-$97.3M	0.14%	159
2021 Q4	$179M	Buy	1,656,679 +1,614,010	+3,783%	+$176M	0.36%	43
2021 Q3	$4.67M	Buy	+42,669	New	+$4.43M	0.02%	973
2021 Q2	–	Sell	-3,097	Closed	-$285K	–	3928
2021 Q1	$285K	Sell	3,097 -72,522	-96%	-$6.12M	﹤0.01%	2144
2020 Q4	$5.53M	Buy	75,619 +65,684	+661%	+$4.88M	0.04%	534
2020 Q3	$772K	Sell	9,935 -104,307	-91%	-$7.18M	0.01%	1110
2020 Q2	$6.35M	Buy	+114,242	New	+$4.89M	0.05%	406
2019 Q2	–	Sell	-40,895	Closed	-$1.08M	–	2094
2019 Q1	$1.08M	Buy	+40,895	New	+$969K	0.01%	904
2016 Q4	–	Sell	-20,886	Closed	-$379K	–	1205
2016 Q3	$379K	Buy	+20,886	New	+$408K	﹤0.01%	832
2015 Q4	–	Sell	-32,809	Closed	-$650K	–	1200
2015 Q3	$650K	Sell	32,809 -121,974	-79%	-$3.85M	0.01%	697
2015 Q2	$5.38M	Sell	154,783 -268,660	-63%	-$8.2M	0.07%	292
2015 Q1	$11M	Buy	423,443 +247,132	+140%	+$4.53M	0.14%	187
2014 Q4	$2.27M	Sell	176,311 -28,037	-14%	-$351K	0.03%	436
2014 Q3	$2.51M	Sell	204,348 -10,812	-5%	-$126K	0.04%	405
2014 Q2	$3.4M	Sell	215,160 -296,063	-58%	-$4.23M	0.05%	317
2014 Q1	$7.73M	Buy	+511,223	New	+$5.77M	0.14%	183

Other funds holding HZNP